Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Epithelial-mesenchymal transition in cutaneous fibrosis disease: from mechanisms to therapy.

Created on 25 Jun 2026

Authors

ShaoXiang Yuan, Ziyi Luo, Nina Yang, Tao Xiong, YueZhong Chen, Xichao Jian, Yun Wang, Shune Xiao, Junzhe Chen, Chengliang Deng

Published in

Frontiers in immunology. Volume 17. Pages 1834346. Epub Jun 09, 2026.

Abstract

Cutaneous fibrosis takes place due to chronic inflammation, tissue trauma, or autoimmune reactions. It is marked by abnormal tissue remodeling; such remodeling is characterized by a raised quantity of myofibroblasts and an excessive accumulation of extracellular matrix (ECM) in the dermis. Therefore, this abnormal process brings about a decrease in tissue function, causes structural irregularities, and thus severely lowers patients' quality of life. Although remarkable progressions have been achieved in preventive and treatment methods, the molecular processes under cutaneous fibrosis are not fully comprehended. Epithelial-mesenchymal transition (EMT) is a dynamic and strictly controlled biological phenomenon where epithelial cells discard their epithelial characteristics and obtain mesenchymal properties. Hence, newly appearing data has demonstrated that EMT plays a critical role in the development of fibrotic disorders. EMT has been proposed as a potential contributor to fibrogenesis, although its quantitative contribution and pathological significance relative to resident fibroblasts and other mesenchymal cell sources remain to be further clarified. These findings not only increase our knowledge of the pathophysiology of cutaneous fibrosis but also identify new molecular targets that can be utilized for therapeutic aims. This review collects the latest progressions in understanding the role of EMT in cutaneous fibrotic disorders. The objective is to provide new understandings into the regulatory mechanisms and possible treatment ways for this condition.

PMID:
42344934
Bibliographic data and abstract were imported from PubMed on 25 Jun 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement